Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 2:28 PM
Ignite Modification Date:
2025-12-25 @ 1:02 PM
NCT ID:
NCT01712659
Group ID:
EG000
Title:
Original Phase II Standard Ruxolitinib Dose Cohort - 20 mg Twice Daily
Description:
Ruxolitinib 20 mg orally twice daily for 28 days. Subject may continue to receive treatment until progressive disease (PD) or unacceptable toxicity.
Deaths Number Affected:
11
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
12
Other Number Affected:
12
Other Number At Risk:
12
Study:
NCT01712659
Results Section:
NCT01712659
Adverse Events Module:
NCT01712659